Empagliflozin is a medication used to treat type 2 diabetes. It belongs to a class of drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by blocking glucose absorption in the kidneys, causing it to be eliminated in the urine. Empagliflozin also helps reduce blood pressure and can help reduce the risk of cardiovascular events such as heart attack and stroke. It is usually taken once daily as a tablet, and can be taken with or without food.
Empagliflozin is a medication used to treat type 2 diabetes, often alongside diet and exercise. Here's a breakdown of how it works and its uses:
How it Works:
Empagliflozin belongs to a drug class called sodium-glucose co-transporter-2 (SGLT2) inhibitors. It works by helping the kidneys remove excess sugar (glucose) from the blood through the urine. Normally, the kidneys reabsorb most of the glucose filtered from the blood back into the bloodstream. Empagliflozin blocks this reabsorption process, allowing more glucose to be excreted in the urine, thereby lowering blood sugar levels.
Uses of Empagliflozin:
- Type 2 Diabetes: Empagliflozin is primarily used to improve glycemic control (blood sugar management) in adults with type 2 diabetes. It can be used as a monotherapy (single medication) or combined with other diabetes medications like insulin or metformin.
- Heart Failure: Studies have shown that Empagliflozin may also offer some benefits for people with heart failure, even if they don't have diabetes. It can help reduce the risk of hospitalization for heart failure and cardiovascular death.
Benefits of Empagliflozin:
- Lowers Blood Sugar: Empagliflozin can be an effective way to manage blood sugar levels in type 2 diabetes.
- May Benefit Heart Health: In some cases, Empagliflozin may offer additional benefits for heart health.
- May Promote Weight Loss: By increasing urinary sugar excretion, Empagliflozin can lead to some modest weight loss.
Important Considerations:
- Not for Everyone: Empagliflozin may not be suitable for everyone with type 2 diabetes, particularly those with severe kidney disease or a history of diabetic ketoacidosis (DKA).
- Increased Urination: One common side effect of Empagliflozin is increased urination, which can lead to dehydration.
- Fungal Infections: There's also a slightly increased risk of developing genital yeast infections with Empagliflozin use.
Brand Names:
Empagliflozin is available under several brand names, including:
- Jardiance®
Disclaimer: This information is for educational purposes only and shouldn't be interpreted as medical advice. Please consult with a healthcare professional for diagnosis and treatment of type 2 diabetes or any other medical condition.